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SUMMARY 
 
Banking of pancreatic islets following cryopreservation has been shown to be the most 
effective method facilitating sufficient availability for transplantation to reverse type 1 
diabetes. As success of transplantation depends on number of functioning islets the aim of this 
study was to determine crucial variables of cryopreservation to increase postthaw viability. 
Isolated rat pancreatic islets were cryopreserved using a protocol systematically changed in 
several variables: (i) freezing media (RPMI-1640 + 10% FCS, 100% FCS, hepatocyte 
suspension buffer); (ii) final concentration of cryoprotectant (Me2SO 5%, 10%, 14.4%, 
18.3%, 21.7%); (iii) conditions of equilibration (15 min vs 45 min, 22°C vs on ice); (iv) 
postthaw removal of cryoprotectant (15 vs 30 min; stepwise vs one-step). Concerning 
freezing media RPMI showed highest viability (60.7±1.5% vs FCS 45.3±1.8%, p<0.05 and 
hepatocyte suspension buffer 56.3±1.4%, ns). Optimal Me2SO concentration revealed to be 
14.4% resulting in 60.5±1.0% viability compared to 22.0±0.9% with 5% Me2SO (p<0.05), 
49.5±1.3% with 10% (p<0.05), 19.6±1.3% with 18.3% (p<0.05) and 8.6±0.8% with 21.7% 
(p<0.05). An equilibration with cryoprotectant on ice showed significantly higher viability 
than at 22°C (66.7±1.1% vs 60.7±1.1%; p<0.05), whereas more rapid equlibration within 15 
min instead of 45 min showed no improvement. For postthaw removal of cryoprotectant 
stepwise dilution within 30 min (68.9±1.1%; 15 min: 68.7±1.2%) was found to be superior to 
a one-step technique (65.6±1.2%; p<0.05). Our study determined freezing media, 
cryoprotectant concentration, conditions of equilibration and postthaw removal of 
cryoprotectant as important parameters giving the opportunity to further advances of low 
temperature banking of isolated islets. 
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INTRODUCTION  
 
Insulin therapy of type 1 diabetes still fails to 
mimic the physiological response of insulin 
secretion (von Mach et al., 2002). Since islet 
transplantation has become an option for the 
treatment of type 1 diabetes (Shapiro et al., 
2000), several methods of isolation, 
purification, and cryopreservation of islets of 
Langerhans have been developed (Kneteman 
et al., 1989; Lakey et al., 1996; Marchetti et 
al., 1994; Miyamoto et al., 1994). Intraportal 
transplantation of isolated islets of 
Langerhans has recently been demonstrated 
to facilitate good glycemic control without 
major surgical risks (Ryan et al., 2001). The 
recent advances were achieved by the 
introduction of a glucocorticoid-free 
immunosuppressive regimen resulting in 
insulin independence in more than 90% of 
type 1 diabetic patients after islet 
transplantation (Shapiro et al., 2000). 
However, in these encouraging studies an 
amount of 9,000 islet equivalents per 
kilogram body weight were required for 
intraportal injection. These high numbers 
outline one of the major problems in islet 
transplantation being the insufficient 
availability of human insulin producing 
tissue. To allow the unlimited collection and 
long-term storage of isolated islets low 
temperature banking after cryopreservation 
has become an important objective in 
investigations concerning islet 
transplantation (Rajotte et al., 1984). Thus, 
cryopreserved isolated human islets have 
successfully been used to increase the 
amount of islets for transplantation in type 1 
diabetic patients (Warnock et al., 1991, 1992, 
1995). Additionally, creating a low-
temperature tissue bank with tissues labeled 
for their type of human leukocyte antigen 
(HLA) would give the opportunity to select 
islet preparations based on the matching of 
type of HLA (Warnock et al., 1994). Before 
transplantation low-temperature banking of 
islets would enable investigators to assess 
islet function and microbiological sterility 
(Lakey et al., 1995). 
 
Unfortunately, reduced recovery, function, 
and viability of islets after thawing has been 
described (Di Carlo et al., 1994; Rich et al., 
1994). As success of transplantation depends 
on the number of functioning islets several 
different protocols for cryopreservation have 
been developed to minimize damage of islet 
cells (Cattral et al., 1998; Lakey et al., 1997; 
Lakey et al., 2001). The aim of this study 
was to determine crucial variables for 
cryopreservation of islets of Langerhans to 
increase postthaw viability. 
 
 
MATERIALS AND METHODS 
 
Pancreatic islets were isolated from male 
Sprague-Dawley rats with a body weight of 
250 – 270 g and 6 – 8 weeks of age (Central 
Animal Facility, University of Mainz). 
Animals were kept under SPF conditions and 
fed ad libitum with Sniff (Soest, Germany) 
standard diet. Anesthesia was performed by 
intraperitoneal injection of pentobarbital at a 
dose of 60 mg/kg, as previously described 
(Jastrow et al., 1997a, b). The peritoneal 
cavity was opened by a midline incision and 
perfusion of the pancreas was performed via 
the pancreatic duct using Hanks’ balanced 
salt solution (HBSS, Gibco BRL, Long 
Island, NY, USA) with a concentration of 
collagenase of 1.7 mg/ml (Serva PanPlus, 
Heidelberg, Germany). The pancreatic organ 
was quickly removed and incubated for 20 
minutes at 37°C in collagenase solution. 
Mechanical disruption of the tissue was 
achieved by intermittent shaking. Enzymatic 
digestion process was finished by adding 
HBSS supplemented with 10% fetal calf 
serum in excess with a temperature of 4°C. 
Pancreatic digest containing endocrine and 
exocrine material was purified using 
discontinuous gradients of Ficoll at densities 
of 1.090, 1.077 and 1.040. Before 
cryopreservation islets were cultured 
overnight in RPMI-1640 medium (Biochrom 
KG, Berlin, Germany) at 37°C in a 
humidified atmosphere of 95% air and 5% 
CO2. The medium was supplemented with 
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5.1 mmol/l glucose, 25 mmol/l HEPES, 10% 
fetal calf serum (Greiner Laboratories, 
Frickenhausen, Germany), 0.2 g/l Glutamax, 
200 U/ml penicillin, 200 µg/ml streptomycin 
(Gibco BRL, Paisley, Scotland, GB) and 50 
µg/ml ciprofloxacin (Bayer, Leverkusen, 
Germany). 
 
Cultured islets were cryopreserved following 
the same protocol being changed 
systematically in several variables as 
described below. Before cryopreservation 
viability assessment was performed using 
propidium iodide staining according to the 
staining protocol of the supplier (Sigma, St. 
Louis, USA). Specimens were scrutinized 
under the fluorescence microscope (Axiovert 
35, XR-X3000, Zeiss, Oberkochem, 
Germany) at normal light and 
monochromatic light using the standard filter 
setup (Beerheide et al., 2002) for 
visualization of propidium iodide which 
penetrates cell membranes of dead cells 
(filter no. 15, BP 546, FT 580, LP 590). This 
procedure allowed the calculation of the 
percentage of viable cells for each islet 
investigated. For example representative 
islets were co-stained using propidium iodide 
marking the dead cells red and fluorescein 
diacetate marking the living cells green as 
previously described (Schneider et al., 2003; 
Zimmermann et al., 2003; Fig. 1). 
Additionally, for n = 16 islets viability 
assessment was performed as well as the 
ATP content (pg/ml) was measured by the 
luciferin/luciferase-technique (Hengstler et 
al., 1999). For the latter experiment islets 
were systematically damaged by heating as 
described previously (Gray and Morris, 
1987; London et al., 1989) to obtain the 
entire range of viabilities between 0% an 
100%. After viability assessment an average 
number of 500 islets was transferred into 
each cryovial (2ml). All viability assessments 
before cryopreservation as well as at 0 h, 24 
h and 48 h post thawing were performed for 
approximately 10% of islets (n = 50). 
 
During the first set of experiments different 
freezing media were tested. Three cryovials 
containing 500 pancreatic islets each 
suspended in culture medium were 
centrifuged for 3 min at 1200 rpm and 4°C. 
The supernatant was discarded and the pellet 
of islets was resuspended in 0.2 ml of one of 
the following solutions: (i) 100% fetal calf 
serum; (ii) hepatocyte suspension buffer 
(HSB; 620 ml glucose solution [9 g D-
glucose/l], 100 ml KH buffer [60 g NaCl/l, 
1.75 g KCl/l and 1.6 g KH2PO4/l], 100 ml 
HEPES buffer [60 g HEPES/l], 150 ml 
amino acid solution [0.27 g/l L-alanine, 0.14 
g/l L-aspartic acid, 0.4 g/l L-asparagine, 0.27 
g/l L-citrulline, 0.14 g/l L-cysteine, 1.0 g/l L-
histidine, 1.0 g/l L-glutamic acid, 1.0 g/l L-
glycin, 0.40 g/l L-isoleucine, 0.8 g/l L-
leucine, 1.30 g/l L-lysine, 0.55 g/l L-proline, 
0.65 g/l L-serine, 1.35 g/l L-threonine, 0.65 
g/l L-tryptophan, 0.55 g/l L-tyrosine, 0.80 g/l 
L-valine], 10 ml glutamine solution [7g L-
glutamine/l], 5 ml insulin solution [2 g 
insulin/l], 8 ml CaCl2 solution [19 g CaCl2 x 
2H2O/l], 4 ml MgSO4 solution [24.6 g/l 
MgSO4 x 7H2O] and 2 g bovine serum 
albumin/l); (iii) RPMI-1640 supplemented 
with 10% fetal calf serum. To the 0.2 ml of 
resuspended islets cryoprotectants were 
added to the resuspended islet pellets in a 
stepwise protocol with at first 0.1 ml of 
14.4% Me2SO (using the respective 
cryopreservation buffer as solvent) was 
added incubating for 5 min at 22 °C (step 
one). After that again 0.1 ml of 14.4% 
Me2SO was added and incubated for 25 min 
at 22 °C resuspending the islet pellets every 5 
min by shaking gently (step two). Then 0.4 
ml 21.7% Me2SO was added resulting in a 
final concentration of cryoprotectant of 
14.4% and incubated for 15 min at 0 °C 
resuspending pellets every 5 min (step three). 
When this prefreezing phase was finished the 
cryovials were transferred into the chamber 
of a computer-controlled freezing machine 
(BV-8, Consarctic, Heidelberg, Germany). 
Freezing included several steps of cooling as 
described below. Immediately after the 
freezing program had been completed the 
cryovials were transferred into liquid 
nitrogen.
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Fig. 1: Rat pancreatic islets under the fluorescence microscope at normal light and 
monochromatic light using the standard filter setup for visualization of propidium 
iodide which penetrates cell membranes of dead cells and fluorescein diacetate 
staining viable cells. This procedure allowed the estimation of the percentage of 
viable cells for each islet investigated (AB: 85%, CD: 35%, EF: 15%) 
 
 
According to the protocol described above 
the concentrations of Me2SO were altered for 
the stepwise equilibration with the 
cryoprotectant resulting in final 
concentrations of 5.0% (0.7 M), 10.0% (1.4 
M), 14.4% (2.0 M), 18.3% (2.6 M) and 
21.7% (3.1 M), respectively. For all 
experiments with different concentrations of 
Me2SO RPMI-1640 supplemented with 10% 
fetal calf serum was used, since this medium 
has been identified to give highest viabilities 
in the previous experiments comparing 
different freezing media. 
 
Different conditions of equilibration with the 
cryoprotectant were tested using RPMI-1640 
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supplemented with 10% fetal calf serum as 
freezing medium and 14.4 % Me2SO as final 
cryoprotectant concentration for all cryovials. 
Pancreatic islets were equilibrated with 
Me2SO using three different protocols: (i) 
islets were treated as described above with 
step one including 5 min of incubation at 22 
°C, step two with 25 min of incubation at 22 
°C, and step three with 15 min of incubation 
at 0 °C; (ii) step one, two and three were all 
performed at 0 °C with the same periods of 
time of incubation; (iii) again each step was 
performed at 0 °C with 5 min of incubation 
for each step resulting in a shortened time of 
equilibration with the cryoprotectant from 45 
to 15 min. 
 
As release of the latent heat of fusion due to 
crystallization during cryopreservation 
causes major damage to cells (Hengstler et 
al., 2000a, b; Steinberg et al., 1999) the 
algorithm of the computer controlled-
freezing machine was optimized towards a 
complete compensation for this effect. For 
each algorithm the temperature in the 
freezing chamber as well as in the islet 
suspension of the cryovial were determined 
and monitored by a chart recorder. At first, 
the critical temperature for occurrence of 
crystallization during freezing of pancreatic 
islets was determined using an almost 
continuous rate of cooling (step 1: duration 
[D] 5 min / final temperature [FT] 0°C; step 
2: D 5 min / FT –5 °C; step 3: D 5 min / FT –
5 °C; step 4: D 140 min / FT –40 °C and 
rapid cooling to –196 °C). Additionally, an 
algorithm resembling the best to date 
protocol for islet cryopreservation was 
applied (step 1: D 5 min / FT 0 °C; step 2: D 
2 min / FT 0 °C; step 3: D 2 min / FT -7.2 
°C; step 4: D 6 min / FT –7.2 °C; step 5: D 
0.5 min / FT –37 °C; step 6: D 0.5 min / FT –
9 °C; step 7: D 5 min / FT –9 °C; step 8: D 
120 min / FT –40 °C and rapid cooling to –
196 °C, for review see Rajotte, 1999). Based 
on these data the algorithm was 
systematically optimized to eliminate the 
peak temperature increase caused by heat of 
fusion using an initial shock cooling step 
(step 1: D 5 min / FT 0 °C; step 2: D 5 min / 
FT -7.2 °C; step 3: D 10 min / FT -7.2 °C; 
step 4: D 0.1 min / FT –33 °C; step 5: D 0.3 
min / FT –9 °C; step 6: D 120 min / FT –40 
°C and rapid cooling to –196 °C). Finally, 
timing and peak of the shock cooling period 
was continuously adapted to prevent a rapid 
loss of temperature in the cryovial (step 1: D 
5 min / FT 0 °C; step 2: D 2 min / FT -4.5 
°C; step 3: D 10 min / FT -4.5 °C; step 4: D 
0.1 min / FT –20 °C; step 5: D 0.1 min / FT –
50 °C; step 6: D 0.2 min / FT –80 °C; step 7: 
D 0.2 min / FT –80 °C; step 8: D 0.5 min / 
FT –5 °C; step 9: D 1 min / FT –7 °C; step 
10: D 5 min / FT –9 °C; step 11: D 120 min / 
FT –40 °C and rapid cooling to –196 °C). 
 
After storage in liquid nitrogen for at least 7 
days, cryovials with frozen islets were 
plunged into a water bath maintained at 37 
°C and rapidly thawed to 0 °C at a rate of 
approximately 200 °C/min. After 
centrifugation at 1200 rpm for 3 min 
supernatant was discarded and the 
intracellular cryoprotectant was removed by 
the addition of 1 ml 0.75 M sucrose solution 
(dissolved in RPMI-1640 supplemented with 
10% fetal calf serum) to the cell pellet and 
incubation for 30 min at 0 °C resuspending 
the cell pellet every 5 min by shaking gently. 
This incubation was followed by a period of 
20 min with repeated addition of 1 ml ice-
cold culture medium (RPMI-1640 
supplemented with 10% fetal calf serum) 
incubating 5 min and resuspension of islets. 
The final suspension was centrifuged at 1200 
rpm for 3 min, resuspended in culture 
medium at 37 °C and transferred to tissue 
culture plates. Viability was determined 
immediately postthawing and after 
maintaining islets in culture for 24 and 48 
hours in a humidified atmosphere as 
described above. Three different protocols 
for the removal of cryoprotectant were tested 
for islets cryopreserved with RPMI-1640 
supplemented with 10% fetal calf serum used 
as freezing medium, a final concentration of 
cryoprotectant of 14.4% and an equilibration 
with cryoprotectant for 15 min at 0 °C as 
described above: (i) after rapid thawing and 
centrifugation the first islet pellet was 
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incubated with 1 ml of 0.75 M sucrose 
solution for 30 min (one-step, 30 min) 
followed by repeated additions of culture 
medium as described above; (ii) incubation 
with 0.75 M sucrose solution in a stepwise 
manner adding 0.17 ml every 5 min for a 
period of 30 min (stepwise, 30 min); (iii) the 
period of incubation was shortened to 15 min 
with a stepwise addition of 0.2 ml 0.75 M 
sucrose solution every 3 min (stepwise, 15 
min). 
 
To assess the in vitro function of the frozen-
thawed pancreatic islets using the protocol 
which resulted in the highest viability in the 
previous experiments the basal and 
stimulated glucose-induced insulin response 
was estimated. After thawing islets were 
cultured for 48 h and washed subsequently. 
Viability was assessed as described above 
using propidium iodide staining. 
Additionally, 18 aliquots of 10 islets were 
incubated in multiwell plates for 60 min in 
RPMI-1640 supplemented with 10% fetal 
calf serum and 2.8 mM of glucose 
concentration. The supernatant was collected. 
Islets were washed and incubated for a 
second period of 60 min in the same media 
with 20 mM of glucose concentration and the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
supernatant was collected. The supernatants 
were frozen (-20 °C) and subsequently 
assayed for insulin content by enzyme 
immunoassay (Mercodia High Range Rat 
Insulin ELISA, Mercodia AB, Uppsala, 
Sweden). The insulin secretion capabilities of 
the islets were expressed as pmol/islet/h and 
compared to 18 aliquots of non-frozen 
controls. The stimulatory response of the 
islets was estimated to be: stimulatory 
response (%) = (stimulation value / basal 
value) * 100 as described previously 
(Schneider et al., 2001). 
 
Results are expressed as mean ± standard 
error of the mean (SEM). The correlation of 
Spearman was used to correlate islet 
viabilities determined by fluorescent staining 
with ATP measurements. As the determined 
viabilities failed testing for equal variance a 
Kruskal-Wallis one way analysis of variance 
(ANOVA) on ranks was used to make 
comparisons between the different groups. If 
an interaction was significant, pairwise 
comparisons of the mean responses to the 
different treatment groups (Dunn´s method) 
were performed. A p-value of smaller than 
0.05 was considered to be statistically 
significant. 
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RESULTS 
 
Results of propidium iodide staining showed 
a strong correlation with the ATP content  
 
(correlation coefficient: R = 0.997; p<0.001; 
Fig. 2). 
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Fig. 2: Islet 
viabilities (percent) 
as determined by 
propidium iodide 
staining in 
correlation to ATP 
content (pg/ml) 
measured by the 
luciferin/luciferase-
technique (n = 16, R 
= 0.997, p<0.001). 
 
Concerning cryopreservation media RPMI-
1640 supplemented with 10% fetal calf 
serum (FCS) showed the highest viability 
with 60.7±1.5% as compared to 100% FCS 
(45.3±1.8%, p<0.05) with no significant 
difference to hepatocyte suspension buffer 
(HSB; 56.3±1.4%). As demonstrated in table 
1 there was no significant loss in viability 
after 24 h and 48 h of culture. 
 
Table 1: Islet viability after thawing using different freezing media: 100% fetal calf 
serum (FCS), hepatocyte suspension buffer (HSB), and RPMI-1640+10% FCS 
 Immediate Postthaw After 24h culture After 48h culture 
100% FCS 47.1±3.1%*† 45.1±3.1%#‡ 43.8±3.1%+¶ 
HSB 55.8±2.3%* 57.1±2.3%# 56.0±2.7%+ 
RPMI-1640 59.6±2.5%† 62.0±2.7%‡ 58.7±2.6%¶ 
Viability of pre-incubated, freshly isolated islets          95.6±0.7% 
Mean ± SEM; *, †, #, ‡, +, ¶ p<0.05 
 
Optimal Me2SO concentration revealed to be 
14.4% resulting in an average viability of 
60.5±1.0% compared to 22.0±0.9% with 5% 
Me2SO (p<0.05), 49.5±1.3% with 10% 
(p<0.05), 19.6±1.3% with 18.3% (p<0.05), 
and 8.6±0.8% with 21.7% (p<0.05). No 
significant decrease or increase of viability 
was observed during 24 h and 48 h of 
postthaw culturing (Table 2). 
 
Table 2: Viability of pancreatic islets following cryopreservation with different 
concentrations of cryoprotectant 
 Immediate Postthaw After 24h culture After 48h culture 
5% Me2SO 22.9±1.4%# 21.6±1.6%# 21.3±1.5%# 
10% Me2SO 48.7±2.2%# 49.8±2.2%*# 50.0±2.2%†# 
14.4% Me2SO 60.9±1.8% 60.5±1.7%* 60.2±1.7%† 
18.3% Me2SO 18.5±2.0%# 20.0±2.4%# 20.5±2.3%# 
21.7% Me2SO 10.1±1.3%# 7.8±1.3%# 8.0±1.3%# 
Viability of pre-incubated, freshly isolated islets          95.8±0.7% 
Mean ± SEM; *, †, #p<0.05 as compared to 14.4% Me2SO 
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Equilibration with cryoprotectant on ice 
showed significantly higher postthaw 
viability than at 22°C (66.7±1.1% vs 
60.7±1.1%; p<0.05), whereas more rapid 
equilibration within 15 min instead of 45 min 
showed no significant improvement 
(67.1±1.1%). Determination of viabilities 24 
h and 48 h after thawing revealed no 
significant changes as compared to viabilities 
immediately measured (Table 3). 
 
Table 3: Postthaw viability of islets using different conditions of equilibration with 
cryoprotectant 
 Immediate Postthaw After 24h culture After 48h culture 
45 min, 22°C 60.9±1.8%*† 60.0±1.9%#‡ 61.1±1.8%+¶ 
45 min, 4°C 66.4±1.9%* 66.4±1.8%# 67.1±2.1%+ 
15 min, 4°C 67.6±1.9%† 66.9±1.8%‡ 66.9±2.1%¶ 
Viability of pre-incubated, freshly isolated islets          95.6±0.7% 
Mean ± SEM; *, †, #, ‡, +, ¶p<0.05 
 
A stepwise postthaw removal of 
cryoprotectant within 30 min was found to 
produce the highest viability with 68.9±1.1% 
as compared to a one-step technique within 
30 min (65.6±1.2%; p<0.05), whereas a 
shortened incubation with sucrose solution of 
only 15 min showed an insignificantly 
decreased viability of 68.7±1.2%. During 
postthaw tissue culture only insignificant 
changes in viability were observed (Table 4). 
 
 
Table 4: Viability assessment of pancreatic islets after removal of cryoprotectant using 
different protocols 
 Immediate Postthaw After 24h culture After 48h culture 
One-step - 30 min 65.6±2.0% 65.8±2.1% 65.3±2.2% 
Stepwise - 30 min 69.1±1.9% 68.7±2.0% 68.9±2.0% 
Stepwise - 15 min 68.4±2.0% 68.7±2.0% 69.1±2.2% 
Viability of pre-incubated, freshly isolated islets          98.8±0.4% 
Mean ± SEM 
 
Cryopreservation of islets using a continuous 
rate of cooling resulted in a marked release 
of heat of fusion at –15 °C causing a 
temperature increase of about 10 °C (Fig. 
3A). Using the algorithm in accordance to 
previously published protocols an initial 
rapid decrease was followed by a rapid 
increase in temperature in the cryovial during 
the critical period of crystallization (Fig. 3B).  
 
 
 
 
 
 
 
 
 
As demonstrated in figure 3 C these changes 
in temperature during crystallization could be 
reduced by precise alterations of extent and 
course of the shock cooling period. To 
eliminate almost any fluctuations of the 
curve of temperature determined in the 
cryovial the onset, extent, course, and 
duration of the shock cooling period was 
optimized (Fig. 3D). 
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Temperature (°C) A      B      C    D 
 
 ↓ ↓ ↓   ↓ ↓ ↓ ↓ ↓ 
Time (min) 
Fig. 3: Influence of the freezing protocol on temperature curves (0 – 50 min) inside 
the cryovials as indicated (↓): 1A - linear freezing protocol; 1B - common freezing 
protocol used for pancreatic islets with shock cooling step; 1C - modification of the 
shock cooling step; 1D - final freezing protocol with only minimal excursions of the 
temperature curve inside the cryovial. - The lower curve demonstrates the 
temperature within the cooling chamber. 
 
 
Investigation of insulin secretion of 
cryopreserved islets using the presently best 
protocol revealed a significantly increased 
basal level of insulin secretion as compared 
to non-frozen controls (Table 5). During 
static incubation with a high glucose 
concentration similar stimulated insulin 
secretion values were observed resulting in a 
reduced stimulatory response of the 
cryopreserved islets compared to non-frozen 
controls. 
 
 
 
Table 5: Assessment of viability and insulin secretion capability of pancreatic islets after 
cryopreservation using the optimized protocol 
 Viability Basal insulin secretion 
(pmol/islet/h) 
Stimulated insulin 
secretion (pmol/islet/h) 
Stimulatory 
response 
Cryopreserved 
islets 
72.0±2.0% 0.27±0.05 0.88±0.16 353±13% 
Non-frozen 
controls 
98.2±0.5% 0.12±0.01 0.70±0.06 568±15% 
 p<0.05 p<0.05 ns P<0.05 
Mean ± SEM 
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DISCUSSION 
 
As the number of pancreatic islet allografts 
performed annually and the number of islet 
transplantation centers has markedly grown 
throughout recent years current methods of 
islet isolation and cryopreservation were 
focused on aiming at successful clinical islet 
transplantation (Brendel et al., 1999). 
Although a number of different protocols 
have been described for the cryopreservation 
of pancreatic islets of Langerhans, most 
involve stepwise equilibration with 2 M 
Me2SO followed by slow cooling and fast 
warming (Lakey et al., 1999; Rajotte, 1999). 
Recently, some key cryobiological 
parameters of islet cells isolated from the 
pancreas of newborn pigs, the osmotically 
inactive fraction of cell volume, the 
permeability coefficients of Me2SO at 
varying temperatures, and the activation 
energies of these transport processes have 
been examined (Fedorow et al., 2001). These 
parameters would permit the mathematical 
modeling of osmotic responses of intact islets 
during the cryopreservation process, which 
may lead to further improvements in the low 
temperature storage of islets from newborn 
pigs. However, current cryopreservation 
protocols are empirically derived. 
 
The aim of the present investigation was to 
determine the influence of four parameters 
on islet viability after cryopreservation: (i) 
freezing media; (ii) concentration of 
cryoprotectant; (iii) conditions of 
equilibration with the cryoprotectant; (iv) 
conditions of removal of the cryoprotectant. 
Among membrane integrity assays most 
commonly trypan blue staining has been used 
for determination of viability in studies 
concerning cryopreservation of pancreatic 
islets. As this method does not guarantee 
reliable data on islet viability usually 
additional tests like glucose challenging 
followed by measurement of insulin 
concentrations or transplantation into 
streptozotocin-induced diabetic animals have 
been performed (Hardikar et al., 2001; 
Stegemann et al., 1998). In the present study 
we applied the technique of fluorescence 
staining with propidium iodide for islet 
viability assessment. Microfluorometric 
counting, for instance, with fluorescein 
diacetate or ethidium bromide have been 
shown to correlate highly significantly on 
low-temperature (24 °C) culture and on 37 
°C culture with the insulin concentrations of 
the same islets (Miyamoto et al., 2000). 
Additionally, we compared propidium iodide 
staining with the luciferin/luciferase-
technique for measurement of ATP content, 
which previously has been used to determine 
the proportion of viable versus dead cells 
(Hengstler et al., 1999). This experiment 
demonstrated a high correlation particular for 
viabilities greater than 40%. 
 
As success of islet cryopreservation also 
depends on a period of culturing prior to the 
freezing procedure all experiments 
performed presently were done after 24 hours 
of incubation. Culture of 2 days after 
isolation of pancreatic islets in medium 
RPMI 1640 before freezing has been shown 
to be superior with respect to insulin 
synthesis and release as compared to freshly 
isolated tissue (McKay and Karow, 1983; 
Sandler and Andersson, 1984). This effect 
was speculated to be due to cell damage 
induced by the collagenase digestion. During 
culture the islets may recover and become 
more resistant to stress associated with 
freezing and thawing. Similarly, different 
degrees of islet viability have been reported 
after thawing during the first days of culture. 
The beneficial effect of culture after thawing 
was supposed to reflect recovery of cells with 
minor freeze-damage or the loss of damaged 
cells, which otherwise would influence the 
results of the viability tests (Sandler and 
Andersson, 1984). For detailed registration of 
such possible influences viability 
assessments in the present study were 
performed immediately, and 24 as well as 48 
hours after thawing. Nevertheless, the present 
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results showed no significant changes in 
viability during this period of time post 
thawing indicating that most pancreatic islets 
immediately and entirely recovered after 
cryopreservation. 
 
Cryopreservation of pancreatic islets is most 
commonly performed using RPMI-1640 or 
TCM-199 supplemented with 10% fetal calf 
serum as freezing media (Rajotte, 1999; 
Sandler and Andersson, 1984). The addition 
of serum has been shown to have beneficial 
effects on postthaw outcome (Sandler et al., 
1987). For hepatocytes of various species we 
previously demonstrated increased postthaw 
viability and a better conservation of 
differentiated functions such as drug 
metabolism and enzyme induction using a 
newly developed hepatocyte suspension 
buffer or a solution of 100% fetal calf serum 
(Hengstler et al., 2000a, b). However, the 
present results showed a significantly lower 
viability using 100% fetal calf serum in 
comparison to RPMI-1640 and hepatocyte 
suspension buffer. Since hepatocyte 
suspension buffer resulted in slightly 
decreased viabilities as compared to RPMI-
1640 the following experiments were 
performed with the latter solution. The 
difference between pancreatic islets and 
hepatocytes was probably due to the fact that 
pancreatic islets are micro-organs consisting 
of about 1000 cells in contrast to single 
hepatic cells which may lead to different 
physico-chemical properties during freezing. 
 
Further improvement of the present 
cryopreservation protocol was achieved by 
the adjustment of the concentration of 
cryoprotectant. One of the mechanisms by 
which addition of cryoprotectants may 
improve survival after cryopreservation is 
through effective dilution of residual salts 
and thereby, avoidance of solution effects 
injury (Mazur, 1970). However, a number of 
studies have shown that cryoprotectants exert 
a wide range of toxic effects on the 
biological systems of various tissues and 
pancreatic islets are no exception (Shlafer, 
1981). For cryopreservation of pancreatic 
islets Me2SO has widely been used (Rajotte 
et al., 1984; Rajotte, 1999). As an alternative 
cryoprotectant ethylene glycol has been 
suggested to be sufficiently useful for rat 
pancreatic islets (Lakex et al., 1995; Sakonju 
et al., 1995). However, recent studies 
revealed higher recovery of human 
pancreatic islets after cryopreservation using 
Me2SO compared to ethylene glycol (Lakey 
et al., 2001). In the present study we 
compared five different Me2SO 
concentrations from 5.0% to 21.7% as most 
frequently concentrations of Me2SO of 7% - 
15% have been applied for cryopreservation 
of pancreatic islets in previous studies 
(Fukushima et al., 1991; Lakey et al., 2001; 
Rich et al., 1993). We observed that 14.4 % 
(2.0 M) resulted in significantly higher 
viability compared to 10.0% and 5.0% as 
well as to 18.3% and 21.7%. In contrast to 
the present findings Lakey et al. (2001) 
demonstrated better results using 1.5 M 
Me2SO in comparison to 2.0 M. However, 
the study of Lakey et al. was performed with 
human pancreatic tissue and no additional 
concentrations of Me2SO were tested (2001). 
Low concentrations of cryoprotectant may 
lead to increased freeze-damage whereas 
high concentrations of cryoprotectant 
probably exert the toxic effects of Me2SO on 
pancreatic islet cells. RPMI-1640 with a 
concentration of 14.4% Me2SO seemed to be 
a solution balancing both effects and 
therefore, was applied in the following 
experiments. 
 
Taylor and Brons (1982) investigated insulin 
secretion and found a two-step technique of 
equilibration with cryoprotectant to produce 
better results as compared to a one-step 
technique. In view of the literature most 
commonly the cryoprotectant was added in a 
stepwise fashion with time allowed between 
the steps for equilibration with the 
cryoprotectant to occur (1995). Therefore, 
presently equilibration with cryoprotectant 
was routinely performed in a stepwise 
manner. Investigating the influence of the 
temperature during equilibration an 
equilibration on ice clearly showed higher 
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viabilities as compared to room temperature. 
Similar results we reported previously for 
isolated hepatocytes focussing on function 
after cryopreservation (Hengstler et al., 
2000a, b). Concerning pancreatic islets 
McKay and Karow (1983) clearly showed 
that the toxic effect of Me2SO on islets was 
suppressed by lowering the temperature of 
exposure. Furthermore, the present data 
support previous findings demonstrating 
exposure to 2.0 M Me2SO at 0°C to be less 
toxic than at 22°C, since the biphasic pattern 
of insulin secretion (Lacy et al., 1972) was 
maintained upon challenge with a high 
concentration of D-glucose (Sakonju et al., 
1996). Additionally, we presently evaluated 
slow and fast equilibration protocols (15 vs 
45 min) and found no significant difference, 
as has recently been demonstrated for human 
islets (Lakey et al., 2001). 
 
Previously, freezing protocols with various 
constant cooling rates have been investigated 
for pancreatic islets. A comparison of 
constant cooling rates of 0.3 °C, 3 °C, 14 °C, 
and 48 °C/min followed by glucose challenge 
testing demonstrated that the slowest cooling 
rate of 0.3 °C/min produced the best outcome 
(McKay and Karow, 1983). This was 
supported by findings for rat pancreatic islets 
showing that cooling at 0.25 °C/min to –40 
°C prior to transferring to liquid nitrogen 
resulted in higher viability than cooling at 0.3 
°C/min to –70 °C and transfer to liquid 
nitrogen (Rich et al., 1993). In contrast to the 
latter, Foreman and Taylor (1989) showed 
slightly suppressed but comparable insulin 
secretion indices of rapidly cooled islets 
(constant cooling rate of -70 °C/min) 
compared with non-frozen cultured islets. 
These findings were supported by 
investigations of hamster pancreatic islets 
demonstrating a constant rapid cooling rate 
of 25 °C/min to be as effective as a slow 
cooling rate of 1 °C/min concerning in vitro 
viability as well as isogenic and xenogenic 
engraftment (Fukushima et al., 1991). In 
view of these conflicting data we only once 
performed cryopreservation of islets using a 
slowly (0.25 °C/min) constant cooling rate to 
determine when crystallization starts under 
our experimental conditions. Reaching a 
temperature of –15 °C the latent heat of 
fusion was suddenly released and the islet 
sample was warmed for approximately 10 
°C. Because this release of heat may be 
deleterious, the optimized protocols for 
cryopreservation of pancreatic islets were 
aiming at minimization of warming by shock 
cooling when crystallization starts (Hengstler 
et al., 2000a, b; Rajotte, 1999). As we 
previously reported for isolated human 
hepatocytes adaptation of the cooling rate 
using a computer-controlled freezing 
protocol including a shock cooling step 
avoided cell damage and increased viability 
from 48% to 86% (Hengstler et al., 2000a; Li 
et al., 1999). Based on the course of the 
temperature curve using a constant cooling 
rate and the best to date protocol the present 
freezing algorithm was continuously 
modified with respect to the timing and 
extent of the shock cooling step. Thereby, the 
temperature curve determined in the cryovial 
with the islets could be trimmed to a constant 
rate of cooling. 
 
For removal of the cryoprotectant after rapid 
thawing of cryopreserved pancreatic islets 
currently a sucrose dilution protocol has most 
widely been used (Rajotte et al., 1995). The 
sucrose dilution protocol exposes the islets to 
a nonpermeating hyperosmolar sucrose 
solution for sufficient time to allow the 
hypertonic intracellular Me2SO to diffuse out 
of the islets (Rajotte et al., 1977). However, 
it has been suggested that sucrose may cause 
osmotic stresses to the frozen-thawed islets 
which may result in some fragmentation 
leading to increased losses during post 
cryopreservation tissue culture (Lakey et al., 
1997). Alternatively, a slow step dilution 
protocol has been described removing the 
hypertonic intracellular Me2SO by 
incremental addition of supplemented 
medium resulting in a slightly hypotonic 
extracellular compartment (Lakey et al., 
1997; Rajotte et al., 1989). In the present 
investigation the standard sucrose dilution 
protocol which involves a one-step addition 
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of 0.75 M sucrose for 30 min prior to serial 
dilutions with supplemented medium was 
modified aiming at a reduction of osmotic 
stresses. Therefore, addition of sucrose using 
a stepwise technique as well as a shorter time 
of equilibration of only 15 min were tested. 
The present study demonstrated that a 
stepwise addition of sucrose significantly 
increased islet viability immediately after 
thawing as well as after two days of tissue 
culture. A time of equilibration of only 15 
min resulted in a slightly lower viability. 
Thus, 15 min seemed to be too short to allow 
the diffusion of the intracellular Me2SO into 
the extracellular compartment. 
 
For functional evaluation of the pancreatic 
islets after thawing insulin secretion was 
investigated during static incubation with low 
and high glucose concentrations using the 
most optimal conditions as determined by the 
previous experiments, e.g. RPMI-1640 
supplemented with 10% fetal calf serum, an 
equilibration with a final concentration of 
14.4 % Me2SO on ice within 15 min, a 
freezing algorithm including a shock cooling 
step to compensate for the release of the 
latent heat of fusion and a stepwise removal 
of cryoprotectant within 30 min. The 
significantly higher basal rates of insulin 
secretion of the frozen-thawed islets 
presently observed corresponded well to 
previous investigations reporting an 
approximately two-fold increase compared to 
non-frozen controls (Lakey et al., 1997; 
Lakey et al., 2001). To exclude an artificial 
increase of the basal insulin secretion values 
possibly caused by an insulin release from 
dead islet tissue the islets were cultured for 
48 hours after thawing and washed 
subsequently. The reason for this effect 
remains to be elucidated. The total amount of 
insulin secretion during incubation with a 
high glucose concentration showed no 
significant difference between cryopreserved 
and non-frozen islets demonstrating the 
preservation of the insulin secretion 
capability. However, the reduced stimulatory 
response indicated a significant functional 
restriction of the cryopreserved pancreatic 
islets what has frequently been observed in 
previous investigations (Gonzalez-Clemente 
et al., 1997; Lakey et al., 1997; Lakey et al., 
2001; McKay and Karow, 1983). 
 
In summary, the present investigation 
determined freezing media, cryoprotectant 
concentration, conditions of equilibration and 
postthaw removal of cryoprotectant as crucial 
parameters of islet cryopreservation. We 
conclude that application of the present 
findings would allow further advances in low 
temperature banking of isolated pancreatic 
islets. 
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